Prostate Cancer Treatment – Radiation vs. Surgery
Being diagnosed with prostate cancer may be a cause of distress for the entire family. Many questions pop-up in a man’s mind when being told
Being diagnosed with prostate cancer may be a cause of distress for the entire family. Many questions pop-up in a man’s mind when being told
Enzalutamide, also known under the branded name Xtandi, has recently received a new FDA approval. In 2012, Enzalutamide was approved for the treatment of Non-Metastatic
The main concern of many men recently diagnosed with prostate cancer is becoming incontinent or impotent after receiving the treatment. When you are diagnosed with
Early results are in from a clinical trial for new prostate cancer treatment drug darolutamide, showcasing the promise of better treatment for specific types of prostate tumors.
Early results in the Phase 2 GALAHAD clinical trial for the anti-cancer drug Zejula show promise in treating patients suffering from specific types of prostate cancer.
A newly-published research study out of Denmark has found that low-dose aspirin, while beneficial for some men’s health issues, does little to help patients diagnosed with prostate cancer.
Researchers have discovered that few patients are using androgen deprivation therapy (ADT) to its fullest advantage despite how effective it is in treating many types of prostate cancer.
New research findings led by scientists from the Mayo Clinic have revealed new molecular markers that can help predict prostate health in patients by aiding in pinpointing tumor severity in “low risk” patients.
A team of researchers from UCLA has found that shorter radiation therapy could have the potential to treat prostate cancer, especially in low-to-moderately-aggressive tumors.
New research sponsored by the makers of the anti-cancer drug Xtandi has revealed the medication can be used to treat more than one type of prostate cancer.